Nothing Special   »   [go: up one dir, main page]

5 Hiv Aids in Pregnancy

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 26

HIV AIDS IN

PREGNANCY
By Mengistu Lopiso , (MD ,GP)

06/06/2022 1
• Learning objectives:
Describe the four prongs of PMTCT
List components of PMTCT
Describe option B+
List the benefits of Option B+

06/06/2022 2
Gynecological Issues
• Conditions causing inflammation or infection increase the
likelihood a woman will acquire or transmit HIV.
• Bacteral vaginosis
• Cervicitis
• Herpes ulcers
• Genital warts
• Condyloma.
• Recurrent candidiasis
• Prevalent in 25 – 30% of women with HIV
• Risk increases 20 fold with CD4 <100.

06/06/2022 3
HIV and Pregnancy
• Pregnancy does not accelerate the progression of HIV disease to AIDS.
• Cd4 count may decrease up to 50 cell/mm3 but return to its pre pregnancy
state.
• Patients with AIDS are more likely to suffer from pregnancy related
complications.

06/06/2022 4
06/06/2022 5
WHO’s 4-prong approach to PMTCT
1. Primary prevention of HIV infection
2. Prevention of unintended pregnancy
3. Prevention of mother to child transmission
4. Linkage to care & support

06/06/2022 6
PRONG 1: Preventing HIV infection among
women of reproductive age
• 50% reduction in the number of women 15–49 years old acquiring HIV
infection by 2015.
• Primary prevention during pregnancy.
• Education about safer sex with use of condoms.
• Early treatment of STIs.
• Safer sex during pregnancy and lactation.
• PICT
• Ensuring comprehensive, correct knowledge about how to prevent HIV
transmission.

06/06/2022 7
Prong 2: Preventing unintended pregnancies
among women living with HIV
• By providing family planning services
• Decreasing the level of unmet need

06/06/2022 8
Prong 3: PMTCT

• Providing ART for the mother


• Safe labor and delivery
• Providing ARV for the neonate
• Exclusive breast feeding up to 6 months

06/06/2022 9
Effect of HIV on pregnancy
• Spontaneous abortion
• IUGR
• Preterm delivery
• Low birth weight
• Still birth
• Perinatal mortality
• New born mortality
• Decreased fertility

06/06/2022 10
Timing of mother to child transmission

During pregnancy
(5-10%)

During labor and delivery (10-20%)

During breastfeeding
(5-10%)

06/06/2022 11
Factors that increase MTCT
Viral
Viral load (the higher the viral load, the greater the risk of HIV transmission)
Viral genotype and phenotype
Viral resistance
Maternal
Maternal immunological status
Maternal nutritional status
New infection with HIV during pregnancy
Maternal clinical status (including co-infection with an STI)
Behavioral factors
Antiretroviral treatment

06/06/2022 12
Obstetrical
Prolonged rupture of membrane (longer than 4 hours)
Mode of delivery
Intrapartum hemorrhage
Obstetrical procedures
Invasive fetal monitoring
Chorioamnionitis
Fetal
Prematurity
Genetic
Multiple pregnancy
06/06/2022 13
Infant
Breastfeeding
Gastrointestinal tract factors
Immature immune system

06/06/2022 14
Option of ARV

06/06/2022 15
•Option B+

06/06/2022 16
What is option B+
“Test and treat” strategy in which triple ARVs are started as soon as
HIV is detected in a pregnant woman irrespective of CD4 count and
gestational age
• Treatment (ART) intended to be given for life
• Specific ART regimen that requires just once a day dosing (either
with one or two tablets), which will result in convenience for the
patient and good drug adherence

06/06/2022 17
What are the Benefits of Option B+
• Requires just one/two pills taken once daily
• No need for CD4 test to initiate ART
• Makes breast feeding safer
• Avoids the need for extended infant ARV prophylaxis (Option A)
• Mothers start treatment early, so quality of life and survival are better
• Maintains continuity of care: ANC to post-weaning so improves infant
testing as well as post-partum uptake of FP services.
• Minimize HIV transmission among discordant partnership
• Ongoing treatment of mother will protect future pregnancies from moment
of conception.
06/06/2022 18
06/06/2022 19
06/06/2022 20
EFV IN PREGNACY
• Better long term viral suppression
• Less adverse effect
• Less risk of resistance

06/06/2022 21
Initiating ART at ANC for HIV positive pregnant/ lactating women

• ART requires 3 different ARVs that act differently in order to


avoid development of drug resistant HIV

• Use standard ARV drugs that are recommended for pregnant


women for Option B+.

• The ART regimen is easy to prescribe and easy to take since it is


available as a once a day single pill

06/06/2022 22
Ethiopia’s 1st Line ART Regimen for HIV
positive pregnant & lactating women
1. Women diagnosed at ANC, labor, or post-partum should started
TDF/3TC/EFV as soon as diagnosed.
2. Women started on TDF/3TC/EFV prior to pregnancy can transfer their ART
care to the PMTCT service provider integrated into MNCH care.
3. Women who get pregnant while on an ART regimen other than
TDF/3TC/EFV should continue the same regimen
4. If woman on a non-TDF/3TC/EFV regimen wishes to have ART managed at
PMTCT site, her ART Clinic provider must determine it is safe to switch
regimens to TDF/3TC/EFV and agree to do so

06/06/2022 23
Detailed option B+: Recommendations

1.During pregnancy:

o TDF/3TC/EFV if for the first time

o Continue same ART regimen if already initiated (unless ART provider

agrees to switch to TDF/3TC/EFV)

o If on AZT prophylaxis; Shift to TDF/3TC/EVF

06/06/2022 24
2. During labor and Delivery:

o If on ART continue same regimen of ART

o For women presenting for the first time initiate TDF/3TC/EFV

o If on AZT prophylaxis; Shift to TDF/3TC/EVF

06/06/2022 25
3. Lactating or post partum.

o Continue ART if started

o Initiate TDF/3TC/EVF if on no treatment

4. Infant regimen: NVP for six weeks post partum

06/06/2022 26

You might also like